Panthera biopartners Headquarters & Office Locations

Panthera biopartners (Private) is headquartered in Preston, Lancashire, United Kingdom. Founded in 2019, the company operates across 1 countries with approximately 123 employees worldwide.

Where is Panthera biopartners's main office?

Panthera biopartners's main headquarters office is located at Preston, Lancashire, GBR, Preston, Lancashire . This serves as the company's primary corporate address and is home to its executive leadership team.

Panthera biopartners regional offices

Beyond its headquarters in Preston, Panthera biopartners maintains 3 offices across 1 countries. Regional offices span 1 countries.

Panthera biopartners contact information

The main switchboard for Panthera biopartners headquarters can be reached at 01772237822. For investor relations, visit panthera-bio.com/investor-relations.

What does Panthera biopartners do?

Panthera Biopartners, established in 2019, is a leading UK-based Site Management Organisation (SMO) specialising in patient recruitment and the execution of clinical trials across various therapeutic areas. Founded by Dr Ian Smith, the originator of Synexus, and Professor John Lyon, a former global executive at Covance, Panthera has rapidly expanded its network to include dedicated clinical trial sites in major UK cities such as Glasgow, London, Manchester, Preston, Sheffield and York The organisation's mission is to enhance healthcare accessibility by conducting clinical research that integrates diverse insights and expertise. Panthera is committed to maintaining rigorous ethical standards and contributing to medical advancements that positively impact health and well-being. Panthera's management team comprises experienced professionals with extensive knowledge in conducting clinical trials across multiple therapy areas and countries. Key figures include Dr Ian Smith (Co-Founder, Director, and Chief Medical Officer), Stuart Young (Chief Executive Officer), and Chris Dodd (Chief Commercial Officer). In October 2024, Panthera became the first UK clinical trial site organisation to join Parexel’s Site Alliance Vaccine Network, a global consortium of high-performing clinical trial sites. This collaboration underscores Panthera's exceptional performance in patient recruitment and its strong partnership with Parexel. Panthera's dedication to innovation and excellence was recognised in October 2023 when it was named Pharma Research Centre of the Year at the Pharma Industry Awards UK. The award highlighted Panthera's innovative SMO model, which emphasises rapid start-up times, access to a vast pool of prequalified patients, and the digitisation of patient engagement processes.